Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
The Journal of Biological Chemistry|June 12, 2004
The topography of transmembrane segment six is altered during the catalytic cycle of P-glycoproteinAlice Rothnie, Janet Storm, Jeff Campbell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2014
The Q loops of the human multidrug resistance transporter ABCB1 are necessary to couple drug binding to the ATP catalytic cycleJoseph K Zolnerciks, Begum G Akkaya, Marjolein Snippe, et al.
Journal of Medicinal Chemistry|September 21, 2016
Class II Phosphoinositide 3-Kinases as Novel Drug TargetsMarco Falasca, Justin R Hamilton, Maria Selvadurai, et al.
Advances in Biological Regulation|March 12, 2019
Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potentialAlice Domenichini, Jeanne S Edmands, Aleksandra Adamska, et al.
Oncogene|September 13, 2002
The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migrationEnza Piccolo, Pasquale F Innominato, Maria A Mariggio, et al.
Cancers|November 6, 2019
Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony FormationIlaria Casari, Alice Domenichini, Simona Sestito, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 25, 2017
Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase PhosphorylationPeter V Simpson, Ilaria Casari, Silvano Paternoster, et al.
The Journal of Pathology|October 11, 2011
Canalicular ABC transporters and liver diseaseMichael Nicolaou, Edward J Andress, Joseph K Zolnerciks, et al.
Scientific Reports|May 19, 2023
Rare variant contribution to cholestatic liver disease in a South Asian population in the United KingdomJulia Zöllner, Sarah Finer, Kenneth J Linton, et al.
Cancers|January 24, 2020
Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer CellsOmar Elaskalani, Alice Domenichini, Norbaini Binti Abdol Razak, et al.
Pageof 17